Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 ... represents an important ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

The company has also filed for FDA approval of its flu+Covid combination vaccine, mRNA-1083. If approved, it will be the first in the US to offer protection against flu and Covid-19 in a single shot.

The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

The delay dovetails with moves by Republican lawmakers in at least 7 states to ban or limit mRNA vaccines. HealthDay News — The US Food and Drug Administration (FDA) has delayed the full ...

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request ...

declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs "are causing permanent harm and deaths." "FDA approval for COVID-19 ...

The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...

But with FDA action, it would be the third vaccine against COVID-19 to receive full FDA approval. Full approval would make the vaccine available beyond an emergency declaration and could provide ...